The Brain's Action-Mode Network

The Brain's Action-Mode Network

Up next

Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 2

In the second episode of this two-part series, Dr. Justin Abbatemarco talks with Drs. Valérie Biousse and Nancy J. Newman about the management of non-arteritic ischemic optic neuropathy and its emerging relationship with GLP‑1 medications. Disclosures can be found at Neurology.or ...  Show more

Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 1

In part one of this two-part series, Dr. Justin Abbatemarco talks with Drs. Valérie Biousse and Nancy J. Newman about the clinical features and diagnostic tools utilized for non-arteritic ischemic optic neuropathy (NAION). Disclosures can be found at Neurology.org. 

Recommended Episodes

A Network of Networks
Data Skeptic

In this episode, Bnaya Gross, a Fulbright postdoctoral fellow at the Center for Complex Network Research at Northwestern University, explores the transformative applications of network science in fields ranging from infrastructure to medicine, by studying the interactions between ...  Show more

Neuroscience - Dr. Andrew Huberman and Brian Mackenzie - Mind States
Collective Insights

The growing understanding of how vision and breathing directly affect the brain—rather than the more generic categories of the mind and emotions is a topic that we find fascinating. And today, in this special encore release from the Collective Insights vault, Dr. Andrew Huberman, ...  Show more

Everyday Neuro 004: Brain Injury, Cognitive Functioning and Concussion in Sport
Everyday Neuro: Psychology and Neuroscience Podcast

In this episode, I discuss brain injury and how it affects the brain, physical abilities, cognition and behaviour. There is a particular focus on traumatic brain injury and how concussion in sport is an area receiving interest from researchers. I interview Brodie Ingham who has i ...  Show more

#21 Unlocking the power of real-world data – Patrick Ryan
Drug Safety Matters

The vast amount of real-world data collected during routine clinical care is a treasure trove of safety information – but there are challenges to overcome before this rich source of evidence can be applied to pharmacovigilance. Patrick Ryan from Johnson & Johnson discusses ...

  Show more